Hans Bitter is Senior Vice President and Head of Data Science at MOMA Therapeutics, a biopharmaceutical company in Brighton, MA, where he leads a team of scientists, engineers, and modelers to mine biological and chemical data to advance research and development efforts. Previously, Hans was Vice President of Data Sciences at bluebird bio, where he developed gene therapies for severe genetic diseases and cancer. Before this, Hans was Global Head of Bioinformatics Oncology at the Novartis Institutes of BioMedical Research, where he oversaw work across the oncology portfolio ranging from target identification (including Project Drive, a systematic interrogation of cancer dependencies across cancer subtypes) to translational biomarker research (including identification of biomarkers of response and resistance to the CD19-targeting CAR T, Kymriah). Prior to NIBR, he was Head of Bioinformatics for Virology and Immunology at Hoffman-LaRoche. Hans began his career at two San Francisco area start-ups and received his PhD from the University of California at Berkeley and his AB from Princeton University.
